Sequel raises $20 million

NovaCardia spinout Sequel (San Diego, Calif.) raised $20 million in a series A round. Investors included Domain Associates; Forward Ventures; InterWest Partners; Montreux Equity Partners; and Skyline Ventures, all of which were previous investors in NovaCardia, which was recently acquired by Merck (MRK) (See BioCentury, July 30, 2007). ...